pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Neurology · news · pharmadog
← back to Neurology
News · Neurology
268
stories
Sep 4, 26
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
stat
Sep 4, 26
STAT+: Top Boston hospitals clash over Medicare Advantage network after split
stat
Sep 4, 26
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
biopharma dive
Sep 4, 26
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
stat
Sep 4, 26
Ionis wins FDA approval of Alexander disease drug zilganersen
endpoints
Sep 4, 26
10 life sciences startups selected for accelerator program
biospace
Sep 4, 26
STAT+: FDA takes another look at botanical drugs
stat
Sep 4, 26
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
biopharma dive
Sep 4, 26
Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
fiercebiotech
Sep 4, 26
Opinion: Make infectious disease data boring again
stat
Sep 3, 26
STAT+: Recipients of gene-edited pig kidneys successfully receive human organs
stat
Sep 3, 26
FDA approves Ionis’ antisense drug as first targeted therapy for Alexander disease
biospace
Sep 3, 26
STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder
stat
Sep 3, 26
FDA Approves First Drug to Treat Alexander Disease
fda press
Sep 3, 26
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
fiercebiotech
Sep 3, 26
SUPPLX.com Issues Voluntary Nationwide Recall of Business Pill and Branch Manager for Men Due to Undeclared Yohimbine
fda recalls
Sep 3, 26
Capricor, Replimune illustrate why FDA must listen to rare disease specialists
biospace
Sep 2, 26
STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial
stat
Sep 2, 26
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharma dive
Sep 2, 26
Novartis’ Rhapsido cuts MS progression in Phase 3 trial, teeing up Roche battle
biospace
Sep 2, 26
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails
biospace
Sep 1, 26
Novartis says MS pill succeeds in two large studies
biopharma dive
Sep 1, 26
Paxlovid did not help long Covid, study finds
stat
Sep 1, 26
Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events
biospace
Aug 31, 26
New guidelines on migraine prevention reflect increasing options for patients
stat
Aug 31, 26
BMS’ neuro renaissance was built on back of Celgene mega-merger
biospace
Aug 31, 26
Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
fda medwatch
Aug 28, 26
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
biospace
Aug 27, 26
CAR Ts will only treat autoimmune diseases if we can scale delivery
biospace
Aug 26, 26
Revival Animal Health, LLC Voluntarily Recalls Feline Milk Replacers Due to Inconsistent Levels of Vitamins and Trace Minerals
fda recalls
← prev
page 3 of 9
next →
